Twist Bioscience Corporation Common Stock (TWST) — Analysis Summary

Twist Bioscience Corporation Common Stock (TWST) has a market cap of $3.70B with year-over-year revenue growth of +20.3%. Net margin stands at -20.6%. The stock trades at a P/E ratio of -47.7.

Key Takeaways

• Revenue changed +20.3% year-over-year
• Net margin of -20.6%
• P/E ratio of -47.7

Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, TWST posted revenue growth of +20.3% and trades at a P/E of -47.7.